14 Mintz Street,
+972 52 839 9570
Surpass Medical, Ltd. (Surpass). Surpass is developing and commercializing the NeuroEndoGraft family of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system.
Surpass Medical was acquired by Stryker on November 01, 2012.
Join Mergr to view all 349 acquisitions of healthcare services companies in 2012, including 60 acquisitions by private equity firms, and 289 by strategics.
Out of 60 sectors in the Mergr database, healthcare services ranked 4 in number of deals in 2012. The largest healthcare services acquisition in 2012 was Amil Participações S.A. - which was acquired by UnitedHealth Group for $4.9B.
Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like Surpass Medical.
No obligation. Cancel anytime.